Published October 28, 2024
| Version v1
Other
Open
Findings from a living systematic review on implementation challenges and lessons learnt regarding deployment of malaria vaccines
Description
In Ghana, the RTS,S malaria vaccine introduction started in 2019, and in April 2023, the FDA approved the use of R21. We aim to provide evidence to policy makers regarding encountered challenges and lessons learnt in relation to malaria vaccine implementation.
Files
UHASRC202411103-2.pdf
Files
(39.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:781508c8090eb720cf9ce8f7acf1c480
|
39.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-10-28University of Health and Allied Sciences